MEAGAN POMERLEAU: Open Payments
NPI 1831656511 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 6 payments from 6 companies in 2025. Trend: 2023 $134 · 2024 $526 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| CVRx, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $106 |
| ABIOMED | 1 | $66 |
Products named: UPTRAVI, Barostim Neo System, Ozempic, BREZTRI, INSPIRE.
Industry payments across FL — which companies pay providers there.
